Published on:

Injunction stops pharmaceutical company from selling unapproved cough and cold products

Federal regulators won an injunction barring a pharmaceutical company from selling more than 50 medications. Most of the barred medications are prescription cough and cold products. The FDA alleged that the drugs were improperly manufactured, carried inadequate directions for use, and were not FDA-approved.

To read more about the barred medication.